172 filings
Page 6 of 9
6-K
4hzcjsogltt6vq8x5rb
19 May 22
Inspira™ Technologies Announces First Quarter 2022 Financial Results
9:05am
EFFECT
odgd4 n026p35z0o
20 Apr 22
Notice of effectiveness
12:15am
POS AM
sql4qdhscma4w3ym
14 Apr 22
Prospectus update (post-effective amendment)
4:40pm
6-K
jtiwc28y
6 Apr 22
Inspira Technologies Announces Deployment Agreement in the Israeli Market to Target $15M
9:25am
20-F
p8dzjm194cdsiahr fi4
31 Mar 22
Annual report (foreign)
4:48pm
6-K
qyo3ycx4
31 Mar 22
Inspira Technologies Releases Q4 & FY2021 Financial Results
4:08pm
6-K
l8o3nr i9xz
3 Feb 22
Inspira Technologies Appointed an Expert in the Field of Artificial Lung as the New Chief Technology Officer (CTO) - Daniella Yeheskely-Hayon PhD
9:06am
6-K
f9966kft
1 Feb 22
Report of Foreign Private Issuer
8:58am
6-K
qto0ijp 23qjc3
31 Jan 22
Inspira Technologies Signs a Strategic Agreement in the U.S. to
9:06am
6-K
uay8i
28 Jan 22
Inspira Technologies Has Listed an FDA Class I 510(k) Exempt component of the ART system
7:36am
6-K
eqt5cedpk
19 Jan 22
Report of Foreign Private Issuer
4:03pm
6-K
3ibbrhbjxzuatn5lma
6 Jan 22
Report of Foreign Private Issuer
6:47am
6-K
h2t lmyuciqh6
20 Dec 21
Report of Foreign Private Issuer
4:05pm
6-K
cvsl64z tlxyb
16 Dec 21
Report of Foreign Private Issuer
4:01pm
6-K
c9dxd 4sfwe
9 Dec 21
Inspira Technologies Signs Strategic Agreement with Innovimed for the Potential Deployment of 1,522 ART Systems in Poland, Czech Republic & Slovakia
7:23am
6-K
nzwjb
30 Nov 21
Prof. Fan currently serves as the medical director of the extracorporeal life support program at the Toronto General Hospital
8:34am
6-K
y0w9jj
23 Nov 21
Inspira Technologies Announces 2021 Third Quarter Financial Results
8:01am
6-K
9gl74en00hoe8lg1sy
23 Nov 21
Report of Foreign Private Issuer
6:09am
6-K
3dszncr8gh
12 Nov 21
Notice of EXTRAORDINARY General Meeting of shareholders
6:02am
EFFECT
z7hiy azynrufx7hc3
1 Nov 21
Notice of effectiveness
12:15am